Most Advocacy Partnership Mistakes Happen Before the First Conversation Patient advocacy organizations play an increasingly important role throughout the clinical development process. They help sponsors understand patient needs, identify participation...
Great Patient Engagement Is Not a Function of Company Size Many emerging biotech companies assume meaningful patient engagement requires large teams, significant budgets, and extensive internal infrastructure. It’s an understandable...
The Best Recruitment Plans Are Built With Patients, Not Just For Patients Sponsors invest significant time developing recruitment strategies, enrollment projections, site activation plans, and outreach initiatives. Yet many recruitment...
Recruitment Challenges Are Often Created Months Before Enrollment Begins Many sponsors view patient engagement as a recruitment activity. As a result, engagement efforts often begin shortly before enrollment starts or...
Patient Interest Alone Does Not Drive Participation Many sponsors assume that awareness is the primary barrier to clinical trial participation. If more patients know about a study, enrollment will improve....
Patient Engagement Is No Longer Optional for Emerging Biotech Companies Emerging biotech companies face a difficult reality. Small teams are often responsible for clinical development, regulatory planning, investor expectations, study...
Just Because Your Team Can Do It Doesn’t Mean They Should Clinical operations teams are being asked to do more than ever before. Enrollment timelines are shrinking. Protocols are becoming...
The Strongest Clinical Trials Are Built With Patients, Not Just For Them Clinical trials are the backbone of life science treatments, providing the data needed to bring new & innovative...
Recruitment Gets the Attention. Retention Determines the Outcome. What happens after a participant enrolls may be more important than how they enrolled in the first place. Many sponsors invest substantial...
